Sponsors should test whether the network has active, engaged investigators in the relevant therapeutic area, not just a list of sites on paper.
Site network guide
Best site network for clinical trials: shortlist for investigator access, diversity, and operational speed.
The best site network is the one that gives sponsors access to the right investigators and patient populations with consistent operational quality and fast startup timelines.
Site location, community relationships, and recruitment infrastructure must align with the diversity targets in the protocol.
Training, SOPs, data quality, and monitoring readiness should be standardised enough to prevent site-level variability from driving programme noise.
Contract templates, regulatory filing readiness, and IRB/EC relationships determine how fast sites can activate.
What to test
Ask whether the site network can actually deliver investigator quality and patient access in the specific therapeutic area and geography required.
- Investigator experience and publication record in the relevant disease area.
- Patient demographics and recruitment track record at network sites.
- Contract and regulatory startup timelines with historical performance data.
Where shortlists fail
Site network shortlists weaken when sponsors choose based on site count without testing therapeutic relevance and operational quality.
- Choosing the largest network when a smaller, therapeutically-focused network would be more effective.
- Underestimating the gap between listed sites and actively enrolling investigators.
- Assuming operational quality is consistent across all network sites.
Use CVC
Compare site network vendors with more structure.
Use the vendor directory to build a shortlist, then use sponsor support if the final process needs more pressure-testing.
Related guide
Best clinical CRO for clinical trials
For clinical CRO comparison including site management and monitoring capabilities, see the clinical CRO guide.
Read the related guide